Alt Text
Office of Neuroscience Research > WUSTL Neuroscience News > NIH Weekly Funding Opportunities, Notices: December 15, 2017

NIH Weekly Funding Opportunities, Notices: December 15, 2017



 Notices

Requests for Applications

     

  • Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity Limited Competition (U01 Clinical Trial Not Allowed)
    (RFA-AA-18-008)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): February 22 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted in response to this funding opportunity announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
    (RFA-DA-19-002)
    National Institute on Drug Abuse
    Application Receipt Date(s): Applications will be accepted on a rolling basis, beginning on January 25, 2018 

     

  • NIDCR Dental Specialty and PhD Program (DSPP)(K12-Clinical Trials Not Allowed)
    (RFA-DE-18-012)
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): February 09, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Microphysiological Systems (MPS) for Modeling Diabetes (UG3/UH3 Clinical Trial Not Allowed)
    (RFA-DK-17-035)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): March 20, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Non-Invasive Diagnostics to Improve Gynecologic Health (R43/R44 - Clinical Trial Optional)
    (RFA-HD-19-006)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): March 30, 2018 , by 5:00 PM local time of applicant organization. 

     

  • Deciphering the Molecular Landscape of Lung Aging in Humans (U01 - Clinical Trial Not Allowed)
    (RFA-HL-19-012)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): February 27, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. 

     

  • BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 - Clinical Trials Not Allowed)
    (RFA-NS-18-014)
    National Institute of Neurological Disorders and Stroke
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    Office of Behavioral and Social Science Research
    Office of Research on Women's Health
    Application Receipt Date(s): March 15, 2018; July 17, 2018; July 15, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 

     

  • BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 - Clinical Trials Optional)
    (RFA-NS-18-018)
    National Institute of Neurological Disorders and Stroke
    National Center for Complementary and Integrative Health
    National Eye Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    Application Receipt Date(s): February 23, 2018, June 6, 2018, October 4, 2018, February 6, 2019, June 4, 2019, October 4, 2019, February 6, 2020, June 4, 2020, and October 6, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. 
Program Announcements

     

  • Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional)
    (PA-18-485)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional)
    (PA-18-491)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)
    (PA-18-492)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)
    (PA-18-493)
    National Cancer Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Academic Research Enhancement Award in Diseases within the Mission of NIDDK (R15 - Clinical Trial Required)
    (PA-18-495)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)
    (PA-18-504)
    National Institutes of Health
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of Biomedical Imaging and Bioengineering
    Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities 
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    National Library of Medicine
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 25, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

     

  • NIDCD Early Career Research(ECR) Award (R21 - Clinical Trials Optional)
    (PAR-18-487)
    National Institute on Deafness and Other Communication Disorders
    Application Receipt Date(s): February 27, 2018; June 26, 2018; October 26, 2018; February 26, 2019; June 26, 2019; October 28, 2019; February 26, 2020; June 26, 2020; October 27, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.